These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3370988)

  • 61. Studies of the mechanism of action of gossypol as a male antifertility agent.
    White IG; Vishwanath R; Swan MA; Brown-Woodman PD
    Contraception; 1988 Mar; 37(3):269-77. PubMed ID: 2836127
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [A beam of dawn light of study on gossypol as a safe, effective, and reversible male antifertility contraceptive--evaluation of the studies by using low dose gossypol combined with steroid hormone for male contraception].
    Xue S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Jun; 22(3):211-3. PubMed ID: 12903461
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Studies on the male antifertility agent gossypol acetic acid: in vitro studies on the effect of gossypol acetic acid on human spermatozoa.
    Kalla NR; Vasudev M
    IRCS J Med Sci; 1980 Jun; 8(6):375-6. PubMed ID: 12336803
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Influence of testosterone substitution on sperm suppression by LHRH agonists.
    Bouchard P; Garcia E
    Horm Res; 1987; 28(2-4):175-80. PubMed ID: 2969861
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of cyproterone acetate on reproductive functions in normal human males.
    Roy S; Chatterjee S; Prasad MR; Poddar AK; Pandey DC
    Contraception; 1976 Oct; 14(4):403-20. PubMed ID: 975826
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
    Furuhjelm M; Carlström K
    Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Limitations in developing gossypol acetic acid as a male contraceptive.
    Lohiya NK; Sharma K; Kumar M; Sharma S
    Contraception; 1990 May; 41(5):519-32. PubMed ID: 2347196
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of gossypol on the motility of mammalian sperm.
    Porat O
    Mol Reprod Dev; 1990 Apr; 25(4):400-8. PubMed ID: 2183832
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Studies on the male antifertility agent gossypol acetic acid. VII. Effect of motility stimulated factors on the revival of human spermatozoal motility after gossypol treatment in vitro.
    Kalla NR; Gadru N; Foo TW
    Andrologia; 1986; 18(4):393-7. PubMed ID: 3019180
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ovarian response in superovulated cycles after suppression with oral contraceptive steroids.
    Burry KA; Greenberg LH; Patton PE
    Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1592-5; discussion 1595-6. PubMed ID: 2048606
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone.
    Wild RA; Demers LM; Applebaum-Bowden D; Lenker R
    Contraception; 1991 Aug; 44(2):113-24. PubMed ID: 1893706
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical trial of gossypol as a male contraceptive drug. Part I. Efficacy study.
    Liu GZ; Lyle KC; Cao J
    Fertil Steril; 1987 Sep; 48(3):459-61. PubMed ID: 3305087
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
    Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Daily serum follicle-stimulating hormone, luteinizing hormone, and plasma testosterone and androstenedione in hirsute women with polycystic sclerotic ovaries: effects of diethylstilbestrol and norethindrone acetats.
    Daane TA; Dignam WJ; Frankland MV; Simmer HH; Parlow AF
    Am J Obstet Gynecol; 1973 Oct; 117(3):392-9. PubMed ID: 4729733
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Effect of low dose gossypol treatment on male sperm nuclear basic protein].
    Cao J; Fei R; Zhao Y; Chen H; Jin W; Chen S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Jun; 22(3):220-2. PubMed ID: 12903463
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical trial of gossypol as a male contraceptive drug. Part II. Hypokalemia study.
    Liu GZ; Lyle KC
    Fertil Steril; 1987 Sep; 48(3):462-5. PubMed ID: 3305088
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interaction of gossypol with sperm macromolecules and enzymes.
    Ueno H; Sahni MK; Segal SJ; Koide SS
    Contraception; 1988 Mar; 37(3):333-41. PubMed ID: 2967157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.